Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
₹66 Cr
P/E Ratio
--
P/B Ratio
1.42
Industry P/E
32.09
Debt to Equity
0.22
ROE
-13.63 %
ROCE
-8.28 %
Div. Yield
0 %
Book Value
7.94
EPS
-0.49
CFO
₹-18.31 Cr
EBITDA
₹-0.72 Cr
Net Profit
₹-10.24 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Vista Pharma
| -4.07 | 2.73 | 11.66 | -16.30 | 7.80 | 11.80 | -4.81 |
|
BSE Healthcare
| -7.68 | 6.11 | -2.04 | 19.11 | 18.77 | 22.70 | 8.84 |
|
BSE Small Cap
| -12.49 | 9.35 | -8.34 | 5.55 | 17.55 | 35.38 | 15.06 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Vista Pharma
| -23.51 | 24.53 | 14.04 | 1.29 | 1.68 | -65.96 | -29.61 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 733.60 | 6,652.58 | 26.68 | 13.8 | |
| 2,322.20 | 9,511.53 | 78.36 | 12.96 | |
| 467.50 | 11,336.49 | 23.66 | 14.4 | |
| 431.60 | 5,319.81 | 71.34 | 6.24 |
1 min read•By Research Desk
Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India, the United States, and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and... liquids covering various therapeutic categories. Vista Pharmaceuticals Limited was incorporated in 1991 and is based in Hyderabad, India. Read more
Incorporated
1991
Chairman
Dhananjaya Alli
Managing Director
Murali Meraga
Headquarters
Nalgonda Dist, Telangana
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Vista Pharmaceuticals Ltd stood at ₹ 64 Cr as on 31-Dec-24
The share price of Vista Pharmaceuticals Ltd is ₹11.30 (BSE) as of 17-Apr-2025 IST. Vista Pharmaceuticals Ltd has given a return of 7.8% in the last 3 years.
Vista Pharmaceuticals Ltd has a market capitalisation of ₹ 66 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Vista Pharmaceuticals Ltd is 1.42 times as on 17-Apr-2025, a 62% discount to its peers’ median range of 3.70 times.
Since, TTM earnings of Vista Pharmaceuticals Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Vista Pharmaceuticals Ltd and enter the required number of quantities and click on buy to purchase the shares of Vista Pharmaceuticals Ltd.
Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India, the United States, and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and liquids covering various therapeutic categories. Vista Pharmaceuticals Limited was incorporated in 1991 and is based in Hyderabad, India.
The promoters of Vista Pharmaceuticals Ltd are VISTA PHARMACEUTICALS INC and DHANANJAYA ALLI. They collectively own 15.38 per cent of the total equity. The chairman of the company is Dhananjaya Alli
There is no promoter pledging in Vista Pharmaceuticals Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,965
|
|
|
9,259
|
|
|
6,153
|
|
|
5,167
|
| Vista Pharmaceuticals Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-6.91
|
|
Operating margin(%)
|
-35.98
|
|
Net Margin(%)
|
-29.83
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Vista Pharmaceuticals Ltd was ₹-3 Cr.
₹0.37
(
